, Tracking Stock Market Picks
Enter Symbol:
Amarin Corporation Plc (AMRN) [hlAlert]

down 4.56 %

Amarin Corporation Plc (AMRN) rated Buy with price target $10 by H.C. Wainwright

Posted on: Thursday,  Mar 12, 2015  8:25 AM ET by HC Wainwright

HC Wainwright rated Buy Amarin Corporation Plc (NASDAQ: AMRN) on 03/12/2015, when the stock price was $2.19. Since
then, Amarin Corporation Plc has lost 4.57% as of 09/08/2015's recent price of $2.09.
If you would have followed this HC Wainwright's recommendation on AMRN, you would have lost 4.56% of your investment in 180 days.

Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical company with a focus on cardiovascular disease. Amarin has a range of clinical and preclinical stage compounds to treat central nervous system (CNS) disorders, including Huntington?s disease, myasthenia gravis and Parkinson?s disease. Its cardiovascular programs and non-core CNS programs include AMR101, EN101, Sublingual Apomorphine and AMR 103. The Company's subsidiaries include Amarin Neuroscience Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma Inc, Amarin Finance Limited and Ester Neurosciences Limited.

HC Wainwright
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2015 8:25 AM Buy
2.19 10.00
as of 8/27/2015
1 Week down  -10.30 %
1 Month down  -18.35 %
3 Months up  10.00 %
1 YTD down  -4.56 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy